Ormat Technologies enters the week with a fresh bearish analyst initiation landing on the same day options defensive positioning reaches its highest recorded level of the year.
The standout event is Bernstein's initiation this morning, which assigned an Underperform rating and a $115 price target — roughly 14% below Monday's close of $133.96. That is the most cautious public stance on ORA from a named firm in the current cycle. The broader analyst picture is more divided. UBS holds a Buy with a $152 target, and Piper Sandler maintains Overweight after lifting its target to $142 last month following Q1 results. JP Morgan sits in the middle at Neutral with a $123 target. The consensus is officially a Hold, and the Bernstein entry pulls the bearish end of the range meaningfully lower — the gap between the most optimistic ($152) and the most pessimistic ($115) is now $37, wider than it has been this year. The bears point to declining electricity revenue, gross margins that compressed to 25.6% in the most recent print versus expectations, and structural pressure on the high-margin electricity segment. Bulls counter with a Product backlog that has grown 79% year-over-year and raised revenue guidance for 2025 into the $960–$980 million range.
Options positioning has extended the defensive tilt flagged in the previous note. The put/call ratio jumped to 1.08 — the highest reading in the 52-week window — from 1.00 the prior session, and the z-score relative to the 20-day mean has moved to 3.2 standard deviations above average. A week ago the prior note flagged a then-record PCR of 1.04; what was a 52-week high then has been surpassed again within days. The pattern is not a one-day spike. The PCR has held above 1.0 every session since mid-May, a sustained defensive skew that has now compounded with a new extreme. The stock is down 3.4% on the day and 3.1% on the week, closing at $133.96.
Short interest tells a less dramatic story than the options market. Bears trimmed again this week — SI is down roughly 7.8% over the past seven days to 7.8% of the free float, extending the unwind from the May peak above 5.2 million shares short. That said, the monthly picture is less clean: shorts are still up 11% over 30 days, meaning the net position remains higher than it was six weeks ago despite the recent retreat. Borrow conditions remain loose. Cost to borrow is 0.59%, a slight tick upward on the week but still well within the low range. Availability has loosened to roughly 216% of short interest — more than twice as much stock available to lend as is currently borrowed — so no squeeze pressure is present in the lending market.
The insider register adds context worth noting. The CFO sold just over $2.7 million of stock across three transactions on May 14, at prices between $133 and $135 — almost exactly where the stock is trading today. Other directors sold smaller amounts across May, and the 90-day net across all insiders is a disposal of approximately $6.2 million. These were mostly pre-scheduled or small-lot sells, but the CFO trade at current price levels is a data point the Bernstein analyst may find supportive of their case. ORTEX factor scores flag a short score rank in the 9th percentile — meaning ORA scores more bearishly on short-interest positioning than 91% of the broader universe — while the EV/EBIT multiple scores in the 7th percentile, indicating expensive relative valuation by that measure.
Q3 earnings are scheduled for August 5. With the Bernstein initiation now anchoring the bear case just below current levels, the next print will be watched closely for any recovery in electricity gross margins and whether the Product backlog translates into recognised revenue — those two numbers, more than the headline beat-or-miss, are what the diverging analyst camps are actually arguing about.
See the live data behind this article on ORTEX.
Open ORA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
